Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory

Lipids

Volumn 45, Issue 3, 2010, Pages 225-236

  Huang, Long Shuang ^a   Hung, Nguyen Dang ^a   Sok, Dai Eun ^a   Kim, Mee Ree ^a  

^a Chungnam National University   (South Korea)

Author keywords

17 HPDHA lysoPtdCho; Anti inflammatory; DHA lysoPtdCho; Docosahexaenoic; LPS; Nitric oxide; RAW 264.7 cell; Zymosan A

Indexed keywords

1 14 HYDROPEROXY 4,7,10,13,15,19 DOCOHEXAENOYL 2 LYSO SN GLYCEROL 3 PHOSPHOCHOLINE; 1 ARACHIDONYL 2 LYSO SN GLYCEROL 3 PHOSPHOCHOLINE; 1 DOCOSAHEXAENOYL 2 LYSO SN GLYCEROL 3 PHOSPHOCHOLINE; 1 LINOLEOYL 2 LYSO SN GLYCEROL 3 PHOSPHOCHOLINE; ANTIINFLAMMATORY AGENT; INTERLEUKIN 6; LEUKOTRIENE C4 SYNTHASE; LYSOPHOSPHATIDYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG EFFICACY; ENZYME REPRESSION; ESTERIFICATION; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PERITONITIS; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; DINOPROSTONE; DOCOSAHEXAENOIC ACIDS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYSOPHOSPHATIDYLCHOLINES; MACROPHAGES; MALE; MICE; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

ANIMALIA;

EID: 77949875588     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-010-3392-5     Document Type: Article

References (47)

1. Daleau P (1999) Lysophosphatidylcholine, a metabolite which accumulates early in myocardium during ischemia, reduces gap junctional coupling in cardiac cells. J Mol Cell Cardiol 31:1391-1401
2. Fuchs B, Schiller J, Wagner U, Häntzschel H, Arnold K (2005) The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. Clin Biochem 38:925-933
3. Muralikrishna Adibhatla R, Hatcher JF (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 40:376-387
4. Triggiani M, Granata F, Frattini A, Marone G (2006) Activation of human inflammatory cells by secreted phospholipases A2. Biochim Biophys Acta 1761:1289-1300
5. Matsumoto T, Kobayashi T, Kamata K (2007) Role of lyso- phosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem 14:3209-3220
6. Shi Y, Zhang P, Zhang L, Osman H, Mohler ER 3rd, Macphee C, Zalewski A, Postle A, Wilensky RL (2007) Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses. Atherosclerosis 191:54-62
7. Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6:1191-1197
8. Farooqui AA, Horrocks LA, Farooqui T (2007) Modulation of inflammation in brain: a matter of fat. J Neurochem 101:577-599
9. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871-1875
10. O'Meara SJ, Rodgers K, Godson C (2008) Lipoxins: update and impact of endogenous pro-resolution lipid mediators. Rev Physiol Biochem Pharmacol 160:47-70
11. Schwab JM, Serhan CN (2006) Lipoxins and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol 6:414-420
12. Kühn H, O'Donnell VB (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 45:334-356
13. Fuentes L, Hernández M, Fernández-Avilés FJ, Crespo MS, Nieto ML (2002) Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: implications for the inflammatory response in atherogenesis. Circ Res 91:681-688
14. Colles SM, Chisolm GM (2000) Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events. J Lipid Res 41:1188-1198
15. Matsubara M, Hasegawa K (2005) Benidipine, a dihydropyri-dine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells. Atherosclerosis 178:57-66
16. Takeshita S, Inoue N, Gao D, Rikitake Y, Kawashima S, Tawa R, Sakurai H, Yokoyama M (2000) Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/ NADPH oxidase. J Atheroscler Thromb 7:238-246
17. Silliman CC, Elzi DJ, Ambruso DR, Musters RJ, Hamiel C, Harbeck RJ, Paterson AJ, Bjornsen AJ, Wyman TH, Kelher M, England KM, McLaughlin- Malaxecheberria N, Barnett CC, Aiboshi J, Bannerjee A (2003) Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol 73:511-524
18. Park CH, Kim MR, Han JM, Jeong TS, Sok DE (2009) Lyso-phosphatidylcholine exhibits a selective cytotoxicity, accompanied by ROS formation, in RAW 264.7 macrophages. Lipids 44:425-435
19. Okita M, Gaudette DC, Mills GB, Holub BJ (1997) Elevated levels and altered fatty acid composition of plasma lysophos-phatidylcholine (lysoPC) in ovarian cancer patients. Int J Cancer 71:31-34
20. Croset M, Brossard N, Polette A, Lagarde M (2000) Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J 345:61-67
21. Adachi J, Asano M, Yoshioka N, Nushida H, Ueno Y (2006) Analysis of phosphatidylcholine oxidation products in human plasma using quadrupole time-of-flight mass spectrometry. Kobe J Med Sci 52:127-140
22. Chen S, Li KW (2007) Mass spectrometric identification of molecular species of phosphatidylcholine and lysophosphatidyl-choline extracted from shark liver. J Agric Food Chem 55:9670-9677
23. Huang LS, Kim MR, Sok DE (2006) Linoleoyl lysophosphati-dylcholine is an efficient substrate for soybean lipoxygenase-1. Arch Biochem Biophys 455:119-126
24. Huang LS, Kim MR, Sok DE (2007) Oxygenation of 1-docosa-hexaenoyl lysophosphatidylcholine by lipoxygenases; conjugated hydroperoxydiene and dihydroxytriene derivatives. Lipids 42:981-990
25. Huang LS, Kim MR, Sok DE (2008) Oxygenation of arachido-noyl lysophospholipids by lipoxygenases from soybean, porcine leukocyte, or rabbit reticulocyte. J Agric Food Chem 56:1224-1232
26. Huang LS, Kim MR, Sok DE (2008) Regulation of lipoxygenase activity by polyunsaturated lysophosphatidylcholines or their oxygenation derivatives. J Agric Food Chem 56:7808-7814
27. Dimitrow PP, Jawien M (2009) Pleiotropic, cardioprotective effects of omega-3 polyunsaturated fatty acids. Mini Rev Med Chem 9(9):1030-1039
28. 2. Prostaglandins 30:769-789
29. Rao TS, Currie JL, Shaffer AF, Isakson PC (1994) In vivo characterization of zymosan-induced mouse peritoneal inflammation. J Pharmacol Exp Ther 269:917-925
30. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang RM, Petasis NA, Serhan CN (2005) Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 20:713-722
31. Leite DF, Echevarria-Lima J, Ferreira SC, Calixto JB, Rumjanek VM (2007) ABCC transporter inhibition reduces zymosan-induced peritonitis. J Leukoc Biol 82(3):630-637
32. Rao NL, Dunford PJ, Xue X (2007) Anti-Inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-Lipoxygenase inhibitor zileuton. J Pharmacol Exp Ther 321:1154-1160
33. Dimitrova P, Ivanovska N (2008) Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation. Int Immuno pharmacol 8(11):1567-1577
34. Griswold DE, Webb EF, Hillegass LM (1991) Induction of plasma exudation and inflammatory cell infiltration by leukotri-ene C4 and leukotriene B4 in mouse peritonitis. Inflammation 15:251-258
35. Xie QW, Whisnant R, Nathan C (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccha-ride. J Exp Med 177:1779-1784
36. Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557-1558
37. Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 206:15-23
38. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196:1025-1037
39. Hassan IR, Gronert K (2009) Acute changes in dietary {omega}-3 and {omega}-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J Immunol 182:3223-3232
40. Hung ND, Kim MR, Sok DE (2009) Anti-inflammatory action of arachidonoyl lysophosphatidylcholine or 15-hydroperoxy derivative in zymosan A-induced peritonitis. Prostaglandins Other Lipid Mediat 90(3-4):105-111
41. Lundy SR, Dowling RL, Stevens TM, Kerr JS, Mackin WM, Gans KR (1990) Kinetics of phospholipase A2, arachidonic acid, and eicosanoid appearance in mouse zymosan peritonitis. J Immunol 144:2671-2677
42. Kolaczkowska E, Arnold B, Opdenakker G (2008) Gelatinase B/ MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific production by mast cells, macrophages, and neutrophils. Immunobiology 213:109-124
43. Kolaczkowska E, Shahzidi S, Seljelid R, Van Rooijen N, Plytycz B (2002) Early vascular permeability in murine experimental peritonitis is comediated by residential macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leu-kotrienes. Inflammation 26:61-71
44. Huwiler A, Pfeilschifter J (2009) Lipids as targets for novel anti-inflammatory therapies. Pharmacol Ther 124(1):96-112
45. Roberts JR, Shaw CF 3rd (1998) Inhibition of erythrocyte sele-nium-glutathione peroxidase by auranofin analogues and metabolites. Biochem Pharmacol 55:1291-1299
46. Maddipati KR, Marnett LJ (1987) Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase. J Biol Chem 262:17398-17403
47. Muñoz NM, Meliton AY, Lambertino A, Boetticher E, Learoyd J, Sultan F, Zhu X, Cho W, Leff AR (2006) Transcellular secretion of group V phospholipase A2 from epithelium induces beta 2-integrin-mediated adhesion and synthesis of leukotriene C4 in eosinophils. J Immunol 177(1):574-582